MGLIX | NRFNX | MGLIX / NRFNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 12 years | - |
Gain YTD | 1.832 | 6.967 | 26% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.41B | 35.9M | 6,699% |
Annual Yield % from dividends | 1.87 | 3.56 | 52% |
Returns for 1 year | 13.95 | 20.25 | 69% |
Returns for 3 years | -18.33 | -11.69 | 157% |
Returns for 5 years | 4.80 | -8.80 | -55% |
Returns for 10 years | 33.01 | -11.19 | -295% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
UIIFX | 27.43 | -0.10 | -0.36% |
Victory International Institutional | |||
MRSIX | 24.06 | -0.21 | -0.87% |
MFS Research International I | |||
SMCIX | 24.64 | -0.23 | -0.92% |
Shelton S&P Smallcap Index Investor | |||
SUHCX | 23.14 | -0.50 | -2.12% |
DWS Health and Wellness C | |||
FBTDX | 124.72 | -6.22 | -4.75% |
Franklin Biotechnology Discovery C |